The data thus far is impressive. Hopefully the next trial will follow suit and build on the momentum from the higher dose as it reaches PR quite swiftly >30% relief in tumor burden. Optimistic they have something special here. Time will tell and think also the US trial will really be a massive value creator with their different SOC. Other targets as well!
- Forums
- ASX - By Stock
- Ann: Presentation and Webinar
The data thus far is impressive. Hopefully the next trial will...
-
- There are more pages in this discussion • 9 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add ATX (ASX) to my watchlist
(20min delay)
|
|||||
Last
13.5¢ |
Change
-0.010(6.90%) |
Mkt cap ! $37.09M |
Open | High | Low | Value | Volume |
14.0¢ | 14.5¢ | 13.0¢ | $71.88K | 525.5K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 101053 | 13.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
14.0¢ | 142339 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 101053 | 0.135 |
4 | 355108 | 0.130 |
3 | 270000 | 0.125 |
5 | 267833 | 0.120 |
4 | 204474 | 0.110 |
Price($) | Vol. | No. |
---|---|---|
0.140 | 142339 | 2 |
0.150 | 140062 | 3 |
0.155 | 149386 | 1 |
0.160 | 110000 | 2 |
0.165 | 291727 | 3 |
Last trade - 16.10pm 28/10/2024 (20 minute delay) ? |
Featured News
ATX (ASX) Chart |